This week's Blue Harbinger Weekly focuses on an uncommon but attractive high-yield REIT investment. We highlight several important considerations and a few things to avoid. If you are an income-focused investor, this one may be worth considering for a position in your diversified portfolio.
If you have a long-term investment horizon, you might consider investing in this disciplined growth stock. It pays only a small dividend now, and its share price is volatile, but 5-years from now you will probably wish (or be glad) that you bought shares.
It may seem counterintuitive, but we just sold one of our top-performing Dividend Aristocrats, and we used the proceeds to buy a “Dog of the Dow” that is currently hated by the market. And as contrarians, we wouldn’t have it any other way.
If you are an income-focused investor, and you occassionally like to take on more aggressive trading opportunities, we have an interesting idea for you that we believe is worth considering.
All Blue Harbinger strategies continue to deliver strong positive returns without any of the full-service brokerage fees that “do-it-yourself investors” are trying to avoid. Our Disciplined Growth portfolio beat the S&P 500 during May, and our Income Equity strategy finished the month with a 5.4% yield, nearly 3.5% higher than the S&P 500. We’ve seen value stocks underperform growth stocks this year, and as contrarians we like value stocks even more now.
Income investors love to own big dividend stocks, but sometimes it’s worthwhile to diversify into companies with smaller albeit growing dividends that also offer significant price appreciation potential. This article reviews one such opportunity that we believe has the opportunity to grow dramatically over time both its dividend and especially its price.
As we've written before, there is a false narrative going around, and it has created an attractive investment opportunity in this big-dividend blue chip stock. And in our view, selling put options on it is particularly attractive right now.
As a follow up to our free article titled “10 Attractive High-Yield Blue Chips, For Contrarians,” this members-only article highlights five more attractive opportunities. And in this case, we currently own all five of these investments.
There was an interesting Warren Buffett interview last week where the “Oracle of Omaha” gave a handful of very wise advice to investors. However, we couldn’t help but notice, he seemed to make a glaring fundamental mistake. This article reviews Buffett’s good advice, postulates a couple reasons why he could have made his glaring fundamental mistake, and we finally offer a smart way (a specific security) to take advantage of Buffett’s good advice without making the same big mistake.
The Dogs of the Dow strategy proposes that an investor invests annually in the ten Dow Jones stocks with the highest dividend yield. Proponents of the strategy argue that blue-chip companies do not alter their dividend to reflect trading conditions and, therefore, the dividend is a measure of the average worth of the company. The following table ranks the 30 Dow Jones stocks by dividend yield, it includes a variety of other financial metrics, and finally we discuss two of our favorite Dogs of the Dow right now.
This week’s Weekly reviews an attractive +7% yield MLP that is on sale. We also review two growth stocks that we own in our Disciplined Growth portfolio. The MLP is very hated (and misunderstood) right now (which is why we like it), and the growth stocks have both rallied hard this year (they’re up 30% and 47%) and we share our views on how to play them going forward.
There’s a false narrative going around, and it has created an attractive investment opportunity in this big-dividend blue chip stock.
This week’s Weekly provides a brief review of every Blue Harbinger holding, including comments, year-to-date price returns and year-to-date total returns (dividends plus price appreciation). We also share market-wide data on what has been working, and what we expect will work going forward.
This report is a continuation of our free public report titled "Top 7 High-Yield Healthcare REITs Worth Considering." However, this members-only report contains the top 3...
This week's Blue Harbinger Weekly covers a new dividend idea. Because of its size and nature, it's often overlooked. However, given its opportunity pipeline and out-sized income, we believe this one is worth considering.
This report is a continuation of our free public report titled "15 Attractive +7% Yields Worth Considering" except in this members-only version, we share the Top 5. We believe all five are extremely attractive high-income opportunities, and we own all 5 of the top 5.
The rally in Dow Jones stocks after President Trump was elected is the largest ever according to data compiled by the Wall Street Journal. However, given the sectors that have been rallying the most, and considering signals from the bond market, we believe now is an attractive time to own dividend stocks, in particular.
We have an important update about Blue Harbinger this week. Additionally, we share 15 specific investment ideas that we believe are extremely attractive right now.
This week's members-only investment idea is an attractive double-digit yielder. This one is a little off the beaten path, but it is highly accessible to investors, and we believe once you have read this article you'll have a better understanding of why we like it so much!
As a follow up to “part I” in this series, this “part II” article highlights more attractive healthy-dividend companies. We’re sticking with the theme that investors should NOT blindly chase after the highest yielding securities, but rather focus on those with the healthiest yields. We highlight a handful of healthy yielders including one that we own in our Blue Harbinger Disciplined Growth portfolio.